Literature DB >> 32891729

Arterial Stiffness Is Associated With Increased Symptom Burden in Patients With Atrial Fibrillation.

Malte Kranert1, Tetyana Shchetynska-Marinova2, Tim Berghoff2, Volker Liebe1, Christina Doesch2, Theano Papavassiliu1, Florian Custodis3, Ibrahim Akin1, Martin Borggrefe1, Anna Hohneck4.   

Abstract

BACKGROUND: Increased arterial stiffness (AS) has been described as a predictor of atrial fibrillation (AF). This study was performed to assess whether increased AS leads to a higher symptom burden in patients with AF.
METHODS: One hundred sixty-two consecutive patients (104 male, 58 female) with diagnosed AF (paroxysmal or persistent) were enrolled. Symptoms most likely attributable to AF were quantified according to the Canadian Cardiovascular Society Severity of Atrial Fibrillation (SAF) scale. AS indices (aortic distensibility, cyclic circumferential strain, and aortic compliance) were characterized using transoesophageal echocardiography.
RESULTS: The cohort was divided into asymptomatic to oligosymptomatic (SAF scale 0-1, n = 78 [48.1%]) and symptomatic (SAF scale ≥ 2, n = 84 [51.9%]) patients. Symptomatic patients tended to be younger (median, 75 [interquartile range (IQR) 67-80] vs 71 [65-79]; P = 0.047) and were more likely to be female (22 [28.2%] vs 36 [42.9%]; P = 0.052). Hypertension was more frequent in symptomatic patients. Aortic compliance indices each were reduced in symptomatic patients, most pronounced for aortic compliance (median, 0.05 [IQR 0.03-0.06] vs 0.04 [0.03-0.05] cm/mm Hg; P = 0.01) followed by cyclic circumferential strain (median, 0.09 [IQR 0.07-0.11] vs 0.07 [0.04-0.10]; P = 0.02) and aortic distensibility (10-3 mm Hg-1, median, 1.74 [IQR 1.34-2.24] vs 1.54 [1.12-2.08]; P = 0.03). Multivariable analysis revealed aortic compliance as an independent predictor for symptoms in patients with AF with an odds ratio of 2.6 (95% confidence interval, 1.2-3.4; P = 0.003).
CONCLUSIONS: AS contributes to a high symptom burden in patients with AF, emphasizing the prognostic role of AS in the early detection and prevention in patients with AF.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32891729     DOI: 10.1016/j.cjca.2020.08.022

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  Network Pharmacology and Pharmacological Mechanism of CV-3 in Atrial Fibrillation.

Authors:  Zundong Wang; Zhen Zeng; Yongsheng Hu; Hengcan Sun; Ying Tang; Weiqin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-14       Impact factor: 2.650

Review 2.  Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Authors:  Stanley Nattel; Philip T Sager; Jörg Hüser; Jordi Heijman; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

3.  Clinical utility of rhythm control by electrical cardioversion to assess the association between self-reported symptoms and rhythm status in patients with persistent atrial fibrillation.

Authors:  Astrid N L Hermans; Nikki A H A Pluymaekers; Theo A R Lankveld; Manouk J W van Mourik; Stef Zeemering; Trang Dinh; Dennis W den Uijl; Justin G L M Luermans; Kevin Vernooy; Harry J G M Crijns; Ulrich Schotten; Dominik Linz
Journal:  Int J Cardiol Heart Vasc       Date:  2021-09-15

4.  Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?

Authors:  J R de Groot; D Linz
Journal:  Neth Heart J       Date:  2022-03-08       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.